These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9394255)
21. Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and Eudragit FS. Zhang F Drug Dev Ind Pharm; 2016; 42(4):563-71. PubMed ID: 26065535 [TBL] [Abstract][Full Text] [Related]
22. Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability. He H; Li H; Tang X Pharm Dev Technol; 2011 Jun; 16(3):212-8. PubMed ID: 20151942 [TBL] [Abstract][Full Text] [Related]
23. Crystal growth formation in melt extrudates. Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578 [TBL] [Abstract][Full Text] [Related]
24. Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30D. Lin AY; Muhammad NA; Pope D; Augsburger LL AAPS PharmSci; 2001; 3(2):E14. PubMed ID: 11741265 [TBL] [Abstract][Full Text] [Related]
25. Accelerated stability of sulphamethoxazole microcapsules coated with Eudragit RS 100 and Eudragit RL 100. Basnet S; Ganesan M; Pal TK Boll Chim Farm; 2002; 141(3):202-9. PubMed ID: 12197419 [TBL] [Abstract][Full Text] [Related]
26. Modeling film-coat non-uniformity in polymer coated pellets: a stochastic approach. Haddish-Berhane N; Jeong SH; Haghighi K; Park K Int J Pharm; 2006 Oct; 323(1-2):64-71. PubMed ID: 16831526 [TBL] [Abstract][Full Text] [Related]
27. Oral controlled release optimization of pellets prepared by extrusion-spheronization processing. Bianchini R; Vecchio C Farmaco; 1989 Jun; 44(6):645-54. PubMed ID: 2803450 [TBL] [Abstract][Full Text] [Related]
28. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride. Chen S; Zhu J; Cheng J Pharmazie; 2007 Dec; 62(12):907-13. PubMed ID: 18214341 [TBL] [Abstract][Full Text] [Related]
29. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension]. Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353 [TBL] [Abstract][Full Text] [Related]
30. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
31. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process. Young CR; Koleng JJ; McGinity JW J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545 [TBL] [Abstract][Full Text] [Related]
32. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique. Kibria G; Ul-Jalil R Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436 [TBL] [Abstract][Full Text] [Related]
33. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Bruce LD; Koleng JJ; McGinity JW Drug Dev Ind Pharm; 2003 Sep; 29(8):909-24. PubMed ID: 14570312 [TBL] [Abstract][Full Text] [Related]
34. Release of chlorpheniramine maleate from fatty acid ester matrix disks prepared by melt-extrusion. Prapaitrakul W; Sprockel OL; Shivanand P J Pharm Pharmacol; 1991 Jun; 43(6):377-81. PubMed ID: 1681047 [TBL] [Abstract][Full Text] [Related]
35. Influence of plasticization time, curing conditions, storage time, and core properties on the drug release from Aquacoat-coated pellets. Wesseling M; Bodmeier R Pharm Dev Technol; 2001 Aug; 6(3):325-31. PubMed ID: 11485174 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of levofloxacin sustained-release capsules. Yin LF; Huang SJ; Jiang SG; Zhao CJ; Pei ZQ; Zhang Q Drug Dev Ind Pharm; 2011 Jan; 37(1):33-40. PubMed ID: 20545503 [TBL] [Abstract][Full Text] [Related]
37. Prolonged release of drug from O/w emulsion and residence in rat nasal cavity. Aikawa K; Matsumoto K; Uda H; Tanaka S; Shimamura H; Aramaki Y; Tsuchiya S Pharm Dev Technol; 1998 Nov; 3(4):461-9. PubMed ID: 9834948 [TBL] [Abstract][Full Text] [Related]
38. Drug release from film-coated chlorpheniramine maleate nonpareil beads: water influx and development of a new drug release model. Tang L; Wigent RJ; Schwartz JB Pharm Dev Technol; 1999; 4(4):481-90. PubMed ID: 10578501 [TBL] [Abstract][Full Text] [Related]
39. Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery. Mathur V; Mudnaik R; Barde L; Roy A; Shivhare U; Bhusari K Acta Pharm; 2010 Mar; 60(1):111-7. PubMed ID: 20228045 [TBL] [Abstract][Full Text] [Related]
40. A multiparticulate drug-delivery system based on pellets incorporated into congealable polyethylene glycol carrier materials. Schmidt C; Bodmeier R Int J Pharm; 2001 Mar; 216(1-2):9-16. PubMed ID: 11274801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]